What is psychedelic therapy and how can it help terminally ill patients?

Psychedelic therapy involves the use of substances like psilocybin in combination with psychological support to help patients explore difficult emotions, shift perspective, and achieve profound psychological breakthroughs. Studies have shown it can reduce depression and anxiety in terminally ill cancer patients.

Why is the UK behind other countries in allowing access to psychedelic treatments?

The UK continues to classify psychedelics as substances of little or no medicinal value, making research and access to these treatments nearly impossible. This is in contrast to countries like Australia, Germany, and Canada, which are beginning to allow access to psychedelics for people with serious or treatment-resistant conditions.

How is the UK's end-of-life bill related to the potential of psychedelic therapy?

The end-of-life bill currently being debated in the UK parliament has sparked a broader conversation about the quality and scope of end-of-life care, highlighting the limits of conventional approaches to psychological suffering. This has led to renewed public interest in the potential role of psychedelic therapy in supporting those facing the emotional and existential challenges of dying.

Home / Health / Psychedelic Therapy Provides Solace for Terminally Ill Patients

Psychedelic Therapy Provides Solace for Terminally Ill Patients

15 Nov

•

Summary

Psychedelic therapy helps terminally ill patients cope with depression, anxiety, and fear of death
UK lags behind other countries in allowing access to psychedelic research and treatments
Public support for relaxing restrictions on psilocybin research, especially for terminal illness

Psychedelic Therapy Provides Solace for Terminally Ill Patients

As of November 15th, 2025, a growing body of evidence suggests that psychedelic therapy could offer significant benefits for terminally ill patients struggling with the emotional and existential challenges of dying. In landmark studies, a high dose of psilocybin combined with psychological support has been shown to rapidly reduce depression and anxiety in cancer patients, with effects lasting up to six months.

Many participants in these studies have reported experiences of deep emotional release, a sense of awe, and a newfound connection that helped them reframe their relationship to death. This contrasts with the limited success of standard treatments like antidepressants and counseling in helping patients fully accept their diagnosis or find meaning in their remaining time.